GPC
40
3
DHI
48
4
NDAQ
62
2
COF
60
2
CPB
30
6
MET
72
5
JPM
69
2
ORCL
65
-2
MCD
52
2
TSCO
49
5
CFG
70
6
MTB
67
2
HOG
35
2
UA
50
-9
IBM
58
-2
SE
61
-4
CA
38
6
KHC
24
13
WFC
79
4
MA
64
7
GPC
40
3
DHI
48
4
NDAQ
62
2
COF
60
2
CPB
30
6
MET
72
5
JPM
69
2
ORCL
65
-2
MCD
52
2
TSCO
49
5
CFG
70
6
MTB
67
2
HOG
35
2
UA
50
-9
IBM
58
-2
SE
61
-4
CA
38
6
KHC
24
13
WFC
79
4
MA
64
7
Financhill
Back

iRhythm Technologies Vs. Perspective Therapeutics Industry Stock Comparison

Sell
30

IRTC
iRhythm Technologies

Last Price:
73.89
Seasonality Move:
17.32%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
30
iRhythm Technologies (IRTC) is a Sell

Is iRhythm Technologies a Buy, Sell or Hold?

  • The current iRhythm Technologies [IRTC] share price is $73.99. The Score for IRTC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • IRTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IRTC Stock Price Chart

What is iRhythm Technologies's stock price today?

  • The iRhythm Technologies share price today is $73.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRTC is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

IRTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 44.02 Sell
Chaikin Money Flow: 165457 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.45 - 85.67) Sell
Bollinger Bands (100): (64.85 - 88.69) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

IRTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.12 Sell
20-day SMA: 80.53 Sell
50-day SMA: 73.04 Buy
200-day SMA: 91.14 Sell
8-day EMA: 77.2 Sell
20-day EMA: 78.03 Sell
50-day EMA: 76.04 Sell
200-day EMA: 85.84 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

iRhythm Technologies Earnings Growth & IRTC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $1.26 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

iRhythm Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):